Registration of colorectal cancer in Scotland: An assessment of data accuracy based on review of medical records
References (23)
- et al.
Multiple genetic alterations in distal and proximal colorectal cancer
Lancet
(1989) - et al.
Confidence intervals and interval cancers … needles and haystacks?
Public Health
(1992) - et al.
Cancer Registration Statistics Scotland 1981–1990
(1993) - et al.
The cancer registry in cancer control: an overview
Review of the Scottish Cancer Registration System
(1990)- et al.
Accuracy of 1990 Cancer Registration Data in Scotland
(1994) - et al.
How accurate are Scottish cancer registration data?
Br J Cancer
(1994) Accuracy of cancer registration
Br J Preventive and Social Med
(1976)- et al.
Accuracy of basic cancer patient data: results from an extensive recoding survey
J Natl Cancer Inst
(1984) - et al.
The Scottish Record Linkage System
Health Bull (Edinb)
(1993)
Manual of the International Classification of Diseases, Injuries and Causes of Death, Ninth Revision
Cited by (13)
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
2007, LancetCitation Excerpt :However, data for cancers were obtained during both trials, and we were fortunate that reliable long-term follow-up was possible via the UK cancer registration system. Studies of this registration system have documented high rates of ascertainment and accuracy for cancer in general,70,71 and for colorectal cancer specifically.72,73 Moreover, under-ascertainment of cancers would, if anything, have attenuated any treatment effect and would not have introduced any systematic bias.
Accuracy of coding for possible warfarin complications in hospital discharge abstracts
2006, Thrombosis ResearchLong-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
2010, The LancetCitation Excerpt :However, data on cancers were collected during all five trials and reliable long-term follow-up was possible (table 1). The UK-based trials contributed more than 90% of the cancer outcomes and studies of the UK cancer registration system have documented very high rates of ascertainment and accuracy for cancer,36,37 and for colorectal cancer specifically.38,39 Indeed, the 4% absolute risk of colorectal cancer during the 20-year follow-up was consistent across the trials (webappendix p 2) and corresponds with the expected rate on the basis of a life-time risk of about 5%.1,2